Anestesiologia e Pesquisa em Ciências Clínicas

Abstrato

Case report on antiphospholipid antibody: clinical research on Asherson syndrome

Thummala Naga Shivani*, Bondula Sai Upendra

Introduction: Thromboses in the arterial and venous systems characterize the Antiphospholipid Syndrome (APS). In the arterial, venous or minor arteries as well as pregnancy morbidity, when antiphospholipid antibody titters are chronically increased. Since virtually any organ can be involved, the clinical presentation of APS is very varied. Abdominal manifestations are rare but may be life threatening and include Budd-Chiari syndrome. We discuss a 26 years old lady with primary APS brought to In March 2017, the Bangabandhu Sheikh Mujib Medical University (BSMMU) in Dhaka, Bangladesh, was established. On aspirin medication with ascites for which she had been receiving treatment for abdominal tuberculosis. Following clinical and laboratory evaluation, she was diagnosed as a case of Budd-Chiari syndrome with portal hypertension and initiated treatment with warfarin.

Main symptom and/or important clinical finding: 25 years old female admitted in Acharya Vinoba Bhave Rural hospital on date 7-07-21 with the chief complaint of excessive breathing, weakness, fatigue, high blood pressure, headache blood clot etc. After physical examination and investigation doctor diagnose a case of antiphospholipid antibody syndrome.

The main diagnoses, therapeutic interventions and outcome: After physical examination and investigation doctor diagnose a case antiphospholipid antibody syndrome medical management was provided to the patient calcium and multivitamin supplementary was given for 7 days to enhance immune function. Tablet valproate 1.5 mg, anticoagulant tablets and atenolol 50 mg beta blocker tablets. Vitamin B12 for supplementary he was taking all treatment and outcome was good.

Conclusion: She was response to all medication as well as doctor treatment and her recovery was good.

Isenção de responsabilidade: Este resumo foi traduzido usando ferramentas de inteligência artificial e ainda não foi revisado ou verificado.